NKGN Kapitalisasi Akuntansi NKGen Biotech

NKGen Biotech, Inc. (NKGN) focuses on developing innovative NK-cell based therapies to combat Alzheimer's disease and is currently in the clinical trial stage. The cultivation process of immune units is automated via robotics, which eliminates human error and facilitates scaling. This chart reflects the current share price, fixed at -0.12, complementing data regarding the company's own cGMP sterile facility in California for the production of biologics.

NKGN Kapitalisasi Buku NKGen Biotech (21.02.2024 - 15.03.2025)

This metric serves as a filter during asset stress testing, allowing for the exclusion of market volatility to assess the intrinsic value of the business. Book capitalization reflects the difference between all assets and liabilities, while the book equity chart for NKGen Biotech, Inc. (NKGN) demonstrates a financial base constrained by the labor intensity of individual cell cultivation, which hinders the rapid scaling of capital through assembly-line production.

Pesaing utama

BIIB: Nilai Buku Bisnis|Nilai Buku Perusahaan Neurocrine Biosciences|RGC (regencellbioscience.com) - Kapitalisasi Akuntansi|Nilai Buku Perusahaan Axsome Therapeutics, Inc. (AXSM)|Kapitalisasi Akuntansi ACADIA Pharma|Xenon Pharmaceuticals Inc - Kapitalisasi Buku|Ekuitas Perusahaan Viking Therapeutics Corp VKTX|Aset Bersih Perusahaan SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Kapitalisasi Buku|Nilai Buku Perusahaan Denali Therapeutics Inc. (DNLI)|HRMY: Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan BHVN|AMLX (Amylyx Corp) - Ekuitas Perusahaan|Nilai Buku Perusahaan Trevi Therapeutics (TRVI)|Kapitalisasi Akuntansi PRAX|Nilai Buku Perusahaan AVXL|Kapitalisasi Buku CeriBell Inc (CBLL)|PRTA (prothena.com) - Kapitalisasi Buku|Nilai Buku Bisnis Alector Inc. ALEC|ANNX (Annexon, Inc.) - Kapitalisasi Buku|OMER: Ekuitas Perusahaan|Nilai Buku Perusahaan Neurogene|Kapitalisasi Akuntansi AC Immune S.A.|VYGR - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan Neumora Corp|Kapitalisasi Buku Scilex Holding Company (SCLX)|Nilai Buku Perusahaan tevogen.com (TVGN)|Kapitalisasi Buku ACOG|cogrx.com - Pambiji Buku Bisnis|IKT (Inhibikase) - Nilai Buku Perusahaan|Cassava Pharma (SAVA) - Ekuitas Perusahaan|ASRT - Aset Bersih Perusahaan|Coya Therapeutics (COYA) - Total Aset Bersih|Kapitalisasi Buku VTGN (VistaGen Therapeutics, Inc.)|Ekuitas Perusahaan Ovid Rx|Kapitalisasi Buku ABOS (Acumen Pharma)|Aset Bersih Perusahaan CervoMed Corporation (CRVO)|Kapitalisasi Buku Alterity Therapeutics Limited|CLNN - Nilai Akuntansi Perusahaan|Aset Bersih Perusahaan PepGen Corp (PEPG)|JUNS - Nilai Akuntansi Perusahaan|Relmada - Kapitalisasi Buku|ANVS (Annovis Bio Corporation) - Pambiji Buku Bisnis|Nilai Buku Perusahaan Grace Therapeutics Inc (GRCE)|Kapitalisasi Akuntansi fireflyneuro.com|Kapitalisasi Buku KLTO (Klotho Neurosciences Inc)|Aset Bersih Perusahaan neurosense-tx.com NRSN|Aset Bersih Perusahaan RVPH|MetaVia Inc. - Pambiji Buku Bisnis|NeurAxis, Inc. (NRXS) - Nilai Buku Perusahaan|HSDT: Kapitalisasi Akuntansi|PASG: Nilai Buku Perusahaan|Neuphoria Therapeutics (NEUP) - Kapitalisasi Buku|Minerva Neurosciences Corp - Kapitalisasi Buku|Nilai Buku Bisnis ATHA|Nilai Buku Perusahaan Addex Therapeutics ADXN|Kapitalisasi Akuntansi ALZN (alzamend.com)|CYCN - Nilai Buku Perusahaan|Kapitalisasi Akuntansi Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Kapitalisasi Buku|Cortigent, Inc. (CRGT) - Ekuitas Perusahaan|ATXI: Aset Bersih Perusahaan|BCLI (brainstorm-cell.com) - Kapitalisasi Buku|CARA - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan CHRO|Eliem Therapeutics - Nilai Buku Perusahaan|Ekuitas Perusahaan ITCI (intracellulartherapies.com)|LBPH - Nilai Buku Perusahaan|marinuspharma.com - Kapitalisasi Akuntansi|NeuroBo Pharmaceuticals, Inc. - Nilai Buku Perusahaan|SAGE - Kapitalisasi Buku|Kapitalisasi Buku SNPX (Neurotrope)|Trevena Inc (TRVN) - Nilai Buku Bisnis|Kapitalisasi Buku VIGL (Vigil Neuroscience Inc.)|Ekuitas Perusahaan WENA|Nilai Buku Perusahaan Cerevel Therapeutics, Inc. CERE